ProShare Advisors’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $287K | Sell |
12,007
-880
| -7% | -$21K | ﹤0.01% | 1470 |
|
2025
Q1 | $320K | Sell |
12,887
-3,116
| -19% | -$77.4K | ﹤0.01% | 1366 |
|
2024
Q4 | $301K | Buy |
16,003
+3,710
| +30% | +$69.9K | ﹤0.01% | 1630 |
|
2024
Q3 | $185K | Buy |
12,293
+2,389
| +24% | +$36K | ﹤0.01% | 1753 |
|
2024
Q2 | $283K | Sell |
9,904
-2,557
| -21% | -$73.2K | ﹤0.01% | 1330 |
|
2024
Q1 | $364K | Buy |
12,461
+924
| +8% | +$27K | ﹤0.01% | 1293 |
|
2023
Q4 | $389K | Buy |
11,537
+1,550
| +16% | +$52.3K | ﹤0.01% | 1205 |
|
2023
Q3 | $306K | Sell |
9,987
-115
| -1% | -$3.53K | ﹤0.01% | 1198 |
|
2023
Q2 | $405K | Buy |
10,102
+376
| +4% | +$15.1K | ﹤0.01% | 1078 |
|
2023
Q1 | $397K | Sell |
9,726
-1,188
| -11% | -$48.5K | ﹤0.01% | 1027 |
|
2022
Q4 | $421K | Buy |
10,914
+860
| +9% | +$33.2K | ﹤0.01% | 1043 |
|
2022
Q3 | $534K | Buy |
10,054
+164
| +2% | +$8.71K | ﹤0.01% | 886 |
|
2022
Q2 | $576K | Sell |
9,890
-4,585
| -32% | -$267K | ﹤0.01% | 894 |
|
2022
Q1 | $1.1M | Sell |
14,475
-2,841
| -16% | -$217K | ﹤0.01% | 881 |
|
2021
Q4 | $1.04M | Buy |
17,316
+1,079
| +7% | +$64.9K | ﹤0.01% | 997 |
|
2021
Q3 | $909K | Sell |
16,237
-4,194
| -21% | -$235K | ﹤0.01% | 933 |
|
2021
Q2 | $1.24M | Buy |
20,431
+1,710
| +9% | +$104K | ﹤0.01% | 915 |
|
2021
Q1 | $1.31M | Buy |
18,721
+1,734
| +10% | +$122K | ﹤0.01% | 846 |
|
2020
Q4 | $1.02M | Buy |
16,987
+4,185
| +33% | +$251K | ﹤0.01% | 874 |
|
2020
Q3 | $770K | Sell |
12,802
-254
| -2% | -$15.3K | ﹤0.01% | 796 |
|
2020
Q2 | $685K | Buy |
13,056
+4,237
| +48% | +$222K | ﹤0.01% | 822 |
|
2020
Q1 | $296K | Sell |
8,819
-6,908
| -44% | -$232K | ﹤0.01% | 877 |
|
2019
Q4 | $712K | Sell |
15,727
-1,213
| -7% | -$54.9K | ﹤0.01% | 927 |
|
2019
Q3 | $645K | Buy |
16,940
+664
| +4% | +$25.3K | ﹤0.01% | 898 |
|
2019
Q2 | $708K | Sell |
16,276
-2,068
| -11% | -$90K | ﹤0.01% | 891 |
|
2019
Q1 | $698K | Buy |
18,344
+227
| +1% | +$8.64K | ﹤0.01% | 910 |
|
2018
Q4 | $779K | Sell |
18,117
-3,467
| -16% | -$149K | 0.01% | 783 |
|
2018
Q3 | $1.06M | Sell |
21,584
-1,760
| -8% | -$86.5K | 0.01% | 801 |
|
2018
Q2 | $748K | Sell |
23,344
-1,604
| -6% | -$51.4K | 0.01% | 945 |
|
2018
Q1 | $777K | Sell |
24,948
-3,837
| -13% | -$120K | 0.01% | 928 |
|
2017
Q4 | $1.31M | Buy |
28,785
+2,398
| +9% | +$109K | 0.01% | 741 |
|
2017
Q3 | $991K | Buy |
26,387
+1,495
| +6% | +$56.1K | 0.01% | 734 |
|
2017
Q2 | $1.19M | Sell |
24,892
-63
| -0.3% | -$3K | 0.01% | 689 |
|
2017
Q1 | $1.14M | Sell |
24,955
-6,144
| -20% | -$280K | 0.01% | 710 |
|
2016
Q4 | $1M | Buy |
31,099
+2,937
| +10% | +$94.8K | 0.01% | 776 |
|
2016
Q3 | $964K | Sell |
28,162
-5,195
| -16% | -$178K | 0.01% | 689 |
|
2016
Q2 | $1.13M | Buy |
33,357
+663
| +2% | +$22.4K | 0.01% | 682 |
|
2016
Q1 | $1.73M | Sell |
32,694
-3,545
| -10% | -$188K | 0.02% | 501 |
|
2015
Q4 | $2.78M | Buy |
36,239
+3,477
| +11% | +$267K | 0.03% | 413 |
|
2015
Q3 | $1.35M | Sell |
32,762
-2,942
| -8% | -$121K | 0.02% | 590 |
|
2015
Q2 | $2.53M | Sell |
35,704
-2,262
| -6% | -$160K | 0.03% | 438 |
|
2015
Q1 | $3.37M | Buy |
37,966
+4,583
| +14% | +$407K | 0.04% | 406 |
|
2014
Q4 | $2.96M | Sell |
33,383
-424
| -1% | -$37.6K | 0.03% | 460 |
|
2014
Q3 | $3.28M | Sell |
33,807
-5,214
| -13% | -$505K | 0.04% | 446 |
|
2014
Q2 | $3.58M | Sell |
39,021
-14,698
| -27% | -$1.35M | 0.05% | 413 |
|
2014
Q1 | $3.76M | Buy |
53,719
+36,950
| +220% | +$2.59M | 0.05% | 375 |
|
2013
Q4 | $964K | Sell |
16,769
-12,342
| -42% | -$710K | 0.01% | 989 |
|
2013
Q3 | $1.4M | Buy |
29,111
+10,802
| +59% | +$519K | 0.03% | 625 |
|
2013
Q2 | $531K | Buy |
+18,309
| New | +$531K | 0.01% | 1292 |
|